Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities
{{output}}
CD123 CAR-T cells (CAR123) represent a promising therapeutic approach for blastic plasmacytoid dendritic cell neoplasm (BPDCN) and CD123+ acute myeloid leukemia (AML). However, the pro-inflammatory environment resulting from CAR-T cell activation can induce CD... ...
